EGFR and neoplasm: EGFR activation is associated with proliferation,antiapoptosis, and metastatic spread, making this pathway a compelling target.Numerous large clinical trials have shown clinical evidence of anticanceractivity with these new agents resulting in improved tumor response andpatients' survival.